SCHEMBL6024657

SCHEMBL6024657

CCCCCC(CN(O)C=O)C(=O)N(NCCCC)C(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.38
POLB P06746 1/20 0.37
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6026290 0.82 MEN1 (0.38) KMT2AMEN1SMN1; SMN2POLBHSD17B10
SCHEMBL2211369 0.75 F2 (0.38) KMT2AMEN1
SCHEMBL15196130 0.75 F2 (0.38) KMT2AMEN1
SCHEMBL6024335 0.74 PDF (0.37)
SCHEMBL9439119 0.73 HSD17B10 (0.48) KMT2AMEN1SMN1; SMN2POLBHSD17B10
SCHEMBL6023686 0.72 BMP1 (0.38)
SCHEMBL6024047 0.72 BMP1 (0.34) KMT2AMEN1
SCHEMBL6023680 0.71 PDF (0.38)
SCHEMBL4659800 0.70 BCHE (0.38)
SCHEMBL4600121 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363873-A4 PEPTIDE DEFORMYLASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2006-01-04 EP claimed
EP-1363873-A2 PEPTIDE DEFORMYLASE INHIBITORS SmithKline Beecham Corporation (US) 2003-11-26 EP claimed
WO-2002070541-A2 PEPTIDE DEFORMYLASE INHIBITORS SMITH KLINE BEECHAM CORPORATION (US) 2002-09-12 WO claimed
EP-1363873-A4 PEPTIDE DEFORMYLASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2006-01-04 EP disclosed
EP-1363873-A2 PEPTIDE DEFORMYLASE INHIBITORS SmithKline Beecham Corporation (US) 2003-11-26 EP disclosed
WO-2002070541-A2 PEPTIDE DEFORMYLASE INHIBITORS SMITH KLINE BEECHAM CORPORATION (US) 2002-09-12 WO disclosed